Following this downgrade, Cerence's twelve analysts are forecasting 2023 revenues to be US$374m, approximately in line with the last 12 months. Statutory earnings per share are supposed to crater 98% to US$0.02 in the same period. Before this latest update, the analysts had been forecasting revenues of US$420m and earnings per share (EPS) of US$1.26 in 2023. It looks like analyst sentiment has declined substantially, with a measurable cut to revenue estimates and a large cut to earnings per share numbers as well.